Skip to main content
Top
Published in: European Archives of Psychiatry and Clinical Neuroscience 2/2012

Open Access 01-03-2012 | Editorial

Neurobiology of schizophrenia: from outcome to pathophysiological insights

Authors: P. Falkai, H. -J. Möller

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 2/2012

Login to get access

Excerpt

Besides positive and negative symptoms, the schizophrenia syndrome is characterized by various deficits in cognitive domains. This progressive neurocognitive impairment deeply impacts the lives of those afflicted and their families and is responsible for worsening of social abilities. In a large-scale naturalistic open-label study of first-episode schizophrenia patients, Segarra et al. [1] have proven that men have an earlier age of onset, poorer premorbid functioning and a higher presence of prodromal and negative symptoms compared with women. Women again show a better social outcome with more stabile relationships. Especially among women, acute stress precedes the onset of psychosis. However, at the 2-year follow-up under risperidone treatment, in both genders, the outcome improved significantly, which was more pronounced in men. However, in this study, non-deficit and chronic schizophrenia patients have been investigated. Réthelyi et al. [2] investigated cognitive functioning including working memory, attention, short-term memory, verbal memory and cognitive flexibility in these both groups and found that patients with deficit schizophrenia suffer from more severe neurocognitive impairment with cognitive flexibility being an independent predictor of outcome. The genetic background may influence cognitive deficits in these patients. Accordingly, Lennertz et al. [3] show the T allele of a promoter variant of the SHANK1 gene leading to impairments in working memory in schizophrenia patients and subjects at risk for psychosis. This is an interesting finding considering that SHANK1 knockout mice entail altered memory functions along with reduced dendritic spines and postsynaptic density, which also are features of schizophrenia. Cognitive test performance also serves as separator between schizophrenia and bipolar disorder. In this context, inhibitory control, which includes aspects of cognitive and behavioral control in processes of maintaining contextual information, may discriminate schizophrenia from affective disorders. Christodoulou et al. [4] detected more pronounced deficits of inhibitory control in schizophrenia patients with familial risk compared to patients with bipolar disorder. …
Literature
1.
go back to reference Segarra R, Ojeda N, Zabala A, García J, Catalán A, Eguíluz JI, Gutiérrez M (2011) Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0218-2 Segarra R, Ojeda N, Zabala A, García J, Catalán A, Eguíluz JI, Gutiérrez M (2011) Similarities in early course among men and women with a first episode of schizophrenia and schizophreniform disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0218-2
2.
go back to reference Réthelyi JM, Czobor P, Polgár P, Mersich B, Bálint S, Jekkel É, Magyar K, Mészáros Á, Fábián Á, Bitter I (2011) General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0224-4 PubMed Réthelyi JM, Czobor P, Polgár P, Mersich B, Bálint S, Jekkel É, Magyar K, Mészáros Á, Fábián Á, Bitter I (2011) General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0224-4 PubMed
3.
go back to reference Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Häfner H, Maier W, Mössner R (2011) A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0233-3 Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Häfner H, Maier W, Mössner R (2011) A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0233-3
4.
go back to reference Christodoulou T, Messinis L, Papathanasopoulos P, Frangou S (2011) Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0213-7 PubMed Christodoulou T, Messinis L, Papathanasopoulos P, Frangou S (2011) Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0213-7 PubMed
5.
go back to reference Peralta V, Basterra V, Campos MS, de Jalón EG, Moreno-Izco L, Cuesta MJ (2011) Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0219-1 PubMed Peralta V, Basterra V, Campos MS, de Jalón EG, Moreno-Izco L, Cuesta MJ (2011) Characterization of spontaneous Parkinsonism in drug-naive patients with nonaffective psychotic disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0219-1 PubMed
6.
go back to reference de Arce Cordzón R, Eding E, Marques-Teixeira J, Milanova V, Rancans E, Schreiner A (2011) Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0220-8 de Arce Cordzón R, Eding E, Marques-Teixeira J, Milanova V, Rancans E, Schreiner A (2011) Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE). Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0220-8
7.
go back to reference Riedel M, Leucht S, Rüther E, Schmauß M, Möller H-J (2011) Critical trial-related criteria in acute schizophrenia studies. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0225-3 Riedel M, Leucht S, Rüther E, Schmauß M, Möller H-J (2011) Critical trial-related criteria in acute schizophrenia studies. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0225-3
8.
go back to reference Möller-Leimkühler AM, Wiesheu A (2011) Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0215-5 Möller-Leimkühler AM, Wiesheu A (2011) Caregiver burden in chronic mental illness: the role of patient and caregiver characteristics. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0215-5
9.
go back to reference Varadarajulu J, Schmitt A, Falkai P, Alsaif M, Turck CW, Martins-de-Souza D (2011) Differential expression of HINT1 in schizophrenia brain tissue. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0216-4 PubMed Varadarajulu J, Schmitt A, Falkai P, Alsaif M, Turck CW, Martins-de-Souza D (2011) Differential expression of HINT1 in schizophrenia brain tissue. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0216-4 PubMed
10.
go back to reference Aslan M, Kocazeybek B, Turan N, Karakose AR, Altan E, Yuksel P, Saribas S, Cakan H, Caliskan R, Torun MM, Balcioglu I, Alpay N, Yilmaz H (2011) Investigation of schizophrenic patients from Istanbul. Turkey for the presence of West Nile virus. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-011-0222-6 PubMed Aslan M, Kocazeybek B, Turan N, Karakose AR, Altan E, Yuksel P, Saribas S, Cakan H, Caliskan R, Torun MM, Balcioglu I, Alpay N, Yilmaz H (2011) Investigation of schizophrenic patients from Istanbul. Turkey for the presence of West Nile virus. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-011-0222-6 PubMed
Metadata
Title
Neurobiology of schizophrenia: from outcome to pathophysiological insights
Authors
P. Falkai
H. -J. Möller
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 2/2012
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-012-0294-y

Other articles of this Issue 2/2012

European Archives of Psychiatry and Clinical Neuroscience 2/2012 Go to the issue